Treatment of climacteric symptoms with an ammonium succinate-based dietary supplement: a randomized, double-blind, placebo-controlled trial

References

• Freeman EW, Sammel MD, Lin H, et al. Duration of menopausal hot flushes and associated risk factors. Obstet Gynecol 2011;117:1095–104
   PubMed Web of Science ®Google Scholar
• Whiteley J, DiBonaventura M, Wagner JS, et al. The impact of menopausal symptoms on quality of life, productivity, and economic outcomes. J Womens Health 2013;22:983–90
   PubMed Web of Science ®Google Scholar
• Williams RE, Kalilani L, DiBenedetti DB, et al. Frequency and severity of vasomotor symptoms among peri- and postmenopausal women in the United States. Climacteric 2008;11:32–43
   PubMed Web of Science ®Google Scholar
• Cho GJ, Lee JH, Park HT, et al. Postmenopausal status according to years since menopause as an independent risk factor for the metabolic syndrome. Menopause 2008;15:524–9
   PubMed Web of Science ®Google Scholar
• Sperling LS, Mechanick JI, Neeland IJ, et al. The cardiometabolic health alliance: working toward a new care model for the metabolic syndrome. J Am Coll Cardiol 2015;66:1050–67
   PubMed Web of Science ®Google Scholar
• Ortmann O, Dören M, Windler E. Hormone therapy in perimenopause and postmenopause (HT). Interdisciplinary S3 Guideline, Association of the Scientific Medical Societies in Germany AWMF 015/062-short version. Arch Gynecol Obstetr 2011;284:343–55
   PubMed Web of Science ®Google Scholar
• Schmidt P. The 2012 hormone therapy position statement of the North American Menopause Society. Menopause 2012;19:257–71
   PubMed Web of Science ®Google Scholar
• Sturdee D, Pines A. Updated IMS recommendations on postmenopausal hormone therapy and preventive strategies for midlife health. Climacteric 2011;14:302–20
   PubMed Web of Science ®Google Scholar
• Sood R, Faubion SS, Kuhle CL, et al. Prescribing menopausal hormone therapy: an evidence-based approach. Int J Womens Health 2014;6:47–57
   PubMedGoogle Scholar
• Hill DA, Hill SR. Counseling patients about hormone therapy and alternatives for menopausal symptoms. Am Fam Physician 2010;82:801–7
   PubMed Web of Science ®Google Scholar
• Loprinzi CL, Qin R, Balcueva EP, et al. Phase III, randomized, double-blind, placebo-controlled evaluation of pregabalin for alleviating hot flashes, N07C1. J Clin Oncol 2010;28:641–7
   PubMed Web of Science ®Google Scholar
• Evans M, Elliott JG, Sharma P, et al. The effect of synthetic genistein on menopause symptom management in healthy postmenopausal women: a multi-center, randomized, placebo-controlled study. Maturitas 2011;68:189–96
   PubMed Web of Science ®Google Scholar
• Chen TT, Maevsky EI, Uchitel ML. Maintenance of homeostasis in the aging hypothalamus: the central and peripheral roles of succinate. Front Endocrinol 2015;6:7. doi: 10.3389/fendo.2015.00007
   PubMed Web of Science ®Google Scholar
• Maevsky EI, Peskov AB, Uchitel ML, et al. A succinate-based composition reverses menopausal symptoms without sex hormone replacement therapy. Adv Gerontol 2008;21:298–305
   PubMedGoogle Scholar
• Harlow SD, Gass M, Hall JE, et al. Executive summary of the Stages of Reproductive Aging Workshop+ 10: addressing the unfinished agenda of staging reproductive aging. Climacteric 2012;15:105–14
   PubMed Web of Science ®Google Scholar
• Greene J. Guide to the Greene climacteric scale. Glasgow: University of Glasgow. 1991
   Google Scholar
• Greene JG. Constructing a standard climacteric scale. Maturitas 1998;29:25–31
   PubMed Web of Science ®Google Scholar
• Ziv-Gal A, Flaws JA. Factors that may influence the experience of hot flushes by healthy middle-aged women. J Womens Health 2010;19:1905–14
   PubMed Web of Science ®Google Scholar
• Freedman RR. Menopausal hot flashes: mechanisms, endocrinology, treatment. J Steroid Biochem Mol Biol 2014;142:115–20
   PubMed Web of Science ®Google Scholar
• Schilling C, Gallicchio L, Miller SR, et al. Genetic polymorphisms, hormone levels, and hot flashes in midlife women. Maturitas 2007;57:120–31
   PubMed Web of Science ®Google Scholar
• Sinchak K, Wagner EJ. Estradiol signaling in the regulation of reproduction and energy balance. Front Neuroendocrinol 2012;33:342–63
   PubMed Web of Science ®Google Scholar
• Skurnick JH, Weiss G, Goldsmith LT, et al. Longitudinal changes in hypothalamic and ovarian function in perimenopausal women with anovulatory cycles: relationship with vasomotor symptoms. Fertil Steril 2009;91:1127–34
   PubMed Web of Science ®Google Scholar
• Toffoletto S, Lanzenberger R, Gingnell M, et al. Emotional and cognitive functional imaging of estrogen and progesterone effects in the female human brain: a systematic review. Psychoneuroendocrinology 2014;50:28–52
   PubMed Web of Science ®Google Scholar
• Long J, He P, Shen Y, Li R. New evidence of mitochondria dysfunction in the female Alzheimer’s disease brain: deficiency of estrogen receptor-β. J Alzheimers Dis 2012;30:545–58
   PubMed Web of Science ®Google Scholar
• Markham A, Bains R, Franklin P, Spedding M. Changes in mitochondrial function are pivotal in neurodegenerative and psychiatric disorders: how important is BDNF? Br J Pharmacol 2014;171:2206–29
   PubMed Web of Science ®Google Scholar
• Velarde MC. Pleiotropic actions of estrogen: a mitochondrial matter. Physiol Genomics 2013;45:106–9
   PubMed Web of Science ®Google Scholar
• Sowers M, Zheng H, Tomey K, et al. Changes in body composition in women over six years at midlife: ovarian and chronological aging. J Clin Endocrinol Metab 2007;92:895–901
   PubMed Web of Science ®Google Scholar
• Scarpulla RC. Transcriptional paradigms in mammalian mitochondrial biogenesis and function. Physiol Rev 2008;88:611–38
   PubMed Web of Science ®Google Scholar
• Osellame LD, Blacker TS, Duchen MR. Cellular and molecular mechanisms of mitochondrial function. Best Pract Res Clin Endocrinol Metabol 2012;26:711–23
   PubMed Web of Science ®Google Scholar
• Fischer-Posovszky P, Wabitsch M, Hochberg Z. Endocrinology of adipose tissue-an update. Horm Metab Res 2007;39:314–21
   PubMed Web of Science ®Google Scholar
• Soni AC, Conroy MB, Mackey RH, Kuller LH. Ghrelin, leptin, adiponectin, and insulin levels and concurrent and future weight change in overweight postmenopausal women. Menopause 2011;18:296
   PubMed Web of Science ®Google Scholar